Latest Breaking News On - Cynata therapeutics - Page 11 : comparemela.com

Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Methods of Commercializing iPSCs are Diverse and Continue to Expand April 13, 2021 06:13 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.com s offering. The main objectives of this report are to describe the current status of iPSC research, patents, funding events, industry partnerships, biomedical applications, technologies, and clinical trials for the development of iPSC-based therapeutics. Since the discovery of induced pluripotent stem cells (iPSCs) a large and thriving research product market has grown into existence, largely because the cells are non-controversial and can be generated directly from adult cells. It is clear that iPSCs represent a lucrative market segment because methods for commercializing this cell type are expanding every year and clinical studies investigating iPSCs are swelling in number.

United statesJames thomsonTakara bioBiocat gmbWaisman biomanufacturingCellgenix gmbShinya yamanakaMasayo takahashiPromocell gmbCell biolabs incMetrion biosciences ltdCategories of research publicationsFate therapeutics incBeckman coulter life sciencesPscs technologyRd systems inc